From Prototype to Profit: Commercialization Insights

ADP nominates tech heavyweights David Kenny and Nancy McKinstry to its board, signaling a strategic pivot toward agentic AI and enterprise SaaS transformation.

Novo Nordisk and Siemens Healthineers are rewriting the commercialization playbook by pairing blockbuster metabolic drugs with accessible blood diagnostics.

Cellular Intelligence assembles a powerhouse advisory board and acquires a Phase 2 Parkinson's therapy to build the first universal model of cell signaling.

Moving past its LeasePlan integration, Ayvens aims to boost shareholder returns via aggressive AI automation and a 100,000-vehicle used EV leasing gamble.

Giant Tiger's $500 micro-grants to local schools for the Terry Fox Run prove that decentralized corporate giving can outmaneuver retail giants.

Siguler Guff's record $3 billion close highlights a massive structural shift as investors abandon over-leveraged mega-caps for founder-owned lower middle-market firms.

As the PFAS crisis deepens, Gabelli's upcoming symposium reveals how Wall Street, tech, and regulators are racing to fix our fractured water infrastructure.

Behind Adeia's recent APAC business awards lies a deliberate IP licensing strategy that is quietly driving the region's massive AI and semiconductor boom.

Amid fierce competition, Travel Answers launches its BOOK26 incentive to capture the late 2026 travel boom, banking on a 35-year evolution and a hybrid advisor model.

EBC Financial Group's win as 'Best CFD Provider' reveals a commercialization strategy built on verifiable regulation and institutional-grade technology.

PBF Energy is replacing pricey 7.875% debt with $500M in 0% exchangeable notes. We decode the savvy financial engineering and its strategic implications.

With its inaugural fund oversubscribed and 70% deployed, Bear Creek Fund Advisors proves its model for finding value in essential housing and healthcare assets.

With the hire of a legal expert, Menlo Business Brokerage is betting that integrated expertise is the key to navigating today's complex M&A landscape.

New Jersey Resources' latest dividend increase isn't just a number. It's the result of a deliberate strategy balancing regulated utilities with clean energy.

As leaders of Prestige Consumer Healthcare prepare for a key investor conference, all eyes are on their strategy for leveraging iconic brands in a complex market.

A new integration embeds AI-native test data directly into UiPath's Test Cloud, aiming to eliminate critical bottlenecks and pave the way for validating enterprise AI agents.

Beyond pencils and notebooks, a lack of hygiene products is a critical barrier to learning. Nancy Torres analyzes Dignity Grows' powerful nonprofit model.

OFA Group's AI platform QikBIM went from zero to 281k views in 90 days, converting its first subscribers and signaling a strategic pivot to software.

With AI facing an "interconnect wall," POET Technologies brings its advanced optical interposer and high-power laser solutions to Asia's premier tech expo.

Facing delisting, BioRestorative executes another reverse split. We dive into whether this financial maneuver can sustain it or just delays the inevitable.